Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)-MedSci.cn

Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)

Huang, LP; Yu, J; Neal, B; Liu, YS; Yin, XJ; Hao, ZX; Wu, YF; Yan, LJL; Wu, JSHY; Joshi, R; Shi, JP; Feng, XX; Zhang, JX; Zhang, YH; Zhang, RJ; Zhou, B; Li, ZF; Sun, JX; Zhao, Y; Yu, Y; Pearson, SA; Chen, ZM; Tian, MY

Tian, MY (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.

Abstract

Background In rural China, mortality surveillance data may be an alternative to primary data collection in clinical trials; SmartVA (verbal autopsy) i......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)

科室

工具

服务